Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Effects of Acute Moderate Hypoxemia on Kinetics of Metoclopramide and its Metabolites in Chronically Instrumented Sheep

  • Kim, Johr (Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Department of Clinical Research, LG Life Sciences, Ltd) ;
  • Riggs, K.-Wayne (Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia) ;
  • Rurak, Dan-W. (Faculty of Medicine, British Columbia Research for Childrens and Womens Health, The University of British Columbia, Vancouver, British Columbia)
  • Published : 2002.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Hypoxemia is known to induce various physiological changes which can result in alteration in drug pharmacokinetics. To examine the effect of acute moderate hypoxemia on metoclopramide (MCP) pharmacokinetics, a continuous 14-hour infusion of MCP during a normoxemic, hypoxemic and subsequent normoxemic period was conducted in eight adult sheep. Arterial blood and urine samples were collected to examine the effects on the pharmacokinetics of MCP and its deethylated metabolites. MCP and its mono- and di-deethylated metabolites were quantitated using a GC/MS method. Steady-state concentrations of MCP were achieved in each of the three periods. During hypoxemia, MCP plasma steady-state concentration increased significantly from 50.72$\pm$1.06 to 63.62$\pm$1.79 ng/mL, and later decreased to 55.83$\pm$1.15 ng/mL during the post-hypoxemic recovery period. Total body clearance ($CL_{TB}$) of MCP was significantly decreased from 274.2$\pm$48.0 L/h to 205.40$\pm$28.2 L/h during hypoxemia, and later restored to 245.8$\pm$44.2 L/h during the post-hypoxemic period. Plasma mono-deethylated MCP concentration (32.78$\pm$1.73 ng/mL) also increased, compared to the control group (21.20$\\pm$1.39 ng/mL), during hypoxemia and subsequent normoxemic period. Renal excretion of MCP and its metabolites was also decreased during hypoxemia, while urine flow was increased with a concomitant decrease in urine osmolality. Thus, the results indicate that acute moderate hypoxemia affects MCP pharmacokinetics.

Keywords

References

  1. Audibert, G., Saunier, C., du Souich, P, In vivo and in vitro effect of cimetidine, inflammation, and hypoxia on propofol kinetics. Drug Metabol. Disp., 21, 7-12 (1992)
  2. Babini, R, du Souich, P, Furosemide pharmacokinetics: effects of respiratory and acid-base disturbances. J. Pharmacol. Exp. Ther., 237, 623-628 (1986)
  3. Bargetzi, M., Aoyama, T., Gonzales, F., Meyer, U., Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clin. Pharmacol. Ther., 46,521-527 (1989) https://doi.org/10.1038/clpt.1989.180
  4. Bateman, D.N., Kahn, C., Davies, D.S., The pharmacokinetics of metoclopramide in human with observation in the dog. Brit. J. Clin. Pharmacol., 9, 327-377 (1980) https://doi.org/10.1111/j.1365-2125.1980.tb01058.x
  5. Baum, D., Porte, D., Stress hyperglycemia and the adrenergic regulation of pancreatic hormones in hypoxia. Metabolism 29 (Suppl 1), 1176-1185 (1980) https://doi.org/10.1016/0026-0495(80)90027-X
  6. Brass, C.A, Narciso, J., Gollan, J.L., Enhanced activity of the free radical producing enzyme xanthine oxidase in hypoxemic rat liver: Regulation and pathological significance. J. Clin. Invest., 87, 424-431 (1991) https://doi.org/10.1172/JCI115013
  7. Colice, G., Yen, S., Ramirez, G., Dietz, J., Ou, L., Acute hypoxia-induced diuresis in rats. Aviation Space Environ. Med., 62, 551-554 (1991)
  8. Cowan, D.A, Huizing, G., Beckett, A.H., Identificationof four new metabolic products of metoclopramide using mass spectrometry. Xenobiotica, 6, 650-616 (1976)
  9. Desmond, P.V., Watson, K.J., Metoclopramide - A Review. Med. J. Australia, 144, 366-368 (1986)
  10. Erickson, R.R., Yu-Drent, P, Holtzman, J., The kinetics of ethyl-morphine N-demethylation in isolated hepatocytes: the effect of drug transport and oxygen concentration. J. Pharmacol. Exp. Ther., 220, 35-38 (1982)
  11. Gleed, R.D., Poore, R, Modification of maternal and fetal oxy-genation with the use of tracheal gas infusion. Am. J. Obst. Gynecol., 155, 429-435 (1986) https://doi.org/10.1016/0002-9378(86)90846-X
  12. Harrington, R. A., Hamiltion, C. W., Brogden, R, Linkewich, J., Romankiswcz J., Hell, R, Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs, 25, 451-494 (1983) https://doi.org/10.2165/00003495-198325050-00002
  13. Hill, K. J., Lumbers, E.R., Renal function in adult and fetal sheep. J. Develop. Physiol., 10, 149 (1988)
  14. Holtzman, J., Gander, J., Erickson, R, The effect of NADH and low oxygen pressure on the hepatic microsomal ethylmorphine N-demethylase activity of the male rat. J. Biol. Chem., 258, 5400-5404 (1983)
  15. Huckabee, W.E., Relationship of pyruvate and lactate during anaerobic metabolism. I. Effects of infusion of pyruvate or glucose and of hyperventilation. J. Clin. Invest., 37, 244-254 (1958) https://doi.org/10.1172/JCI103603
  16. Jones, D., Hypoxia and drug metabolism. Bioehem. Pharmacol., 30, 1019-1023 (1981) https://doi.org/10.1016/0006-2952(81)90436-6
  17. Jurgens, G, Christensen, H. R, Brosen, K., et al., Acute hypoxia and chromosome P450-mediated drug metabolism in humans. Clinc. Pharmacol. Ther., 71, 214-220 (2002) https://doi.org/10.1067/mcp.2002.121789
  18. Kapil, R, Axelson, J.E., Ongley, R, Price, J., Nonlinear bioavailablity of metoclopramide in rat: evidence for saturable fist-pass metabolism. J. Pharm. Sci., 73, 215-216 (1984) https://doi.org/10.1002/jps.2600730218
  19. Kennedy, J. M., Riji, A. M., Effect of surgery on the pharmacokinetic parameters of drugs. Clin. Pharmaeokinet., 35, 292-312 (1998)
  20. Letarte, L., du Souich, P., Influence of hypercapnia and/or hypoxemia and metabolic acidosis in theophylline kinetics in the conscious rabbit. Am. Rev. Respir. Dis., 129, 762-766 (1984) https://doi.org/10.1164/arrd.1984.129.5.762
  21. M. Roland, T.N. Tozer: Clinical Pharmacokinetics. 2nd ed. Lea & Febiqer, Philadelphia, PA (1989)
  22. Marleau, S., Ong, H., Gariepy, L., du Souich, P., Lidocaine and Indocyanine kinetics: effects of hypoxemia and/or hypercapnia. J. Pharmacol. Exp., Ther. 242, 338-343 (1987)
  23. Mathie, R.T, Blumgart, L., Effect of denervation on the hepatic haemodynamic response to hypercapnia and hypoxia in the dog. Pfluger Archiv., 397, 152-157 (1983) https://doi.org/10.1007/BF00582055
  24. Ng, C. Y, Ghabrial, H., Morgan, D. J., Ching, M. S. et al., Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and Its relationship to intrinsic Metabolic Capacity. Drug Metab. Disp., 28, 1217-1221 (2000)
  25. Proulx M., du Souich, P., Influence of hypoxia induced oxidative stress on cytochrome P-450. Eur. J. Pharmacol., 183, 1361 (1990)
  26. Riggs, K.W., Szeitz, A., Rurak, DW., Mutlib, A.E., Abbott, F.S., Axeson, J.E., Analysis of metoclopramide and two of its metabolites using a sensitive and selective gas chromatographic assay with mass selective detection. J. Chromatogr. B. Biomed Appl. , 660, 315-325 (1994) https://doi.org/10.1016/0378-4347(94)00314-9
  27. Rizza, R.A., Cryer, P.E., Haymond, M., Gerich, J., Adrenergic mechanism for the effects of epinephrine on glucose production and clearance in man. J. Clin. lnvest. 65, 682-689 (1980) https://doi.org/10.1172/JCI109714
  28. Saunier, C., du Souich, P, Theophylline disposition during acute and chronic hypoxia in the conscious dog. Res. Comm. Crem. Path. Pharmacol., 57, 291-299 (1987)
  29. du Souich, P., Clozel, P., Saunier, C., Ong, H., Hartemann, D., Garcia-Carmona, T., Sadoul, P, Influence of hypoxemia and respiratory acidosis on the plasma kinetics and tissue distribution of digoxin in the conscious dog. Can. J. Physiol. Pharmacol., 63, 72-77 (1985) https://doi.org/10.1139/y85-013
  30. du Souich, P., Courteau, H., Influence of hypercapnia and(or) hypoxemia and metabolic acidosis on sulfamethazine kinetics in the conscious rabbit. Can. J. Physiol. Pharmacol., 62, 1170-1177 (1984) https://doi.org/10.1139/y84-196
  31. du Souich, P, Saunier, C., Hartemann, D., Allan, M., Effect of acute and chronic hypoxia on the kinetics of lidocaine and its metabolite and on regional blood flow. Pulmonary Pharmacol., 5, 9-16 (1992) https://doi.org/10.1016/0952-0600(92)90012-6
  32. du Souich, P., Varin, F., Courteau, H., Effect of hypercapnia and/or hypoxemia and metabolic acidosis on the kinetics and concentrations of phenytoin in the cerebrospinal fluid of conscious rabbits. Neuropharmacol., 25, 857-862 (1986) https://doi.org/10.1016/0028-3908(86)90011-0
  33. Teng, T., Bruce, R.B., Dunning, L.K., Metoclopramide metabolism and determination by high-pressure liquid chromatography. J. Pharm. Sci., 66, 1615-1617 (1977) https://doi.org/10.1002/jps.2600661128
  34. Tsuru, M., Erickson, R.R, Holtzman, J.: The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats. J. Pharmacol. Exp. Ther., 222, 658-661 (1982)
  35. W.F. Ganong: Review of Medical Physiology. Lange Medical Publications, Los Altos, CA (1985)
  36. Walker B.R, Diuretic response to acute hypoxia in the conscious dog. Am. J. Physiol., 243, F440-446 (1982)
  37. Zborowska-Sluis, D. T., Dossetor, J. B., Hyperlactatemia of hyperventilation. J. Appl. Physiol., 22, 746-755, (1967)